References
- Reubinoff B E, Schenker J G. HELLP syndrome -a syndrome of hemolysis, elevated liver enzymes and low platelet count—complicating preeclampsia-eclampsia. J Gynecology Obstetrics 1991; 36: 95–102
- Ballegeer V, Spitz B, Kieckens L., Moreau H, Van Assche F A. Predictive value of fibronectin levels in normotensive gravid women destined to become preeclamptic. Am J Obstet Gynecol. 1989; 161: 432–36
- Ballegeer V, Spitz B, De Baene L, Van Assche F A, Hidajat M, Criel A. Platelet activation and vascular damage in gestational hypertension. Am J Obstet Gynecol. 1992; 166: 629–33
- Goodlin R C. HELLP does not mean immediate HELP. Am J Obstet Gynecol. 1990; 163: 1089
- Weiner C P. The role of serotonin in the genesis of hypertension in preeclampsia. Am J Obstet Gynecol. 1987; 156: 885–88
- De Clerck F, de Chaffoy de Courcelles. Amplification mechanisms in platelet activation. Blood Cells and Arteries in Hypertension and Atherosclerosis, P Meyer, P Marche. Raven Press, New York 1989; 105–40
- Weiner C P, Socol M L, Vaisrub N. Control of preeclamptic hypertension by ketanserin, a new serotonin antagonist. Am J Obstet Gynecol. 1984; 149: 496–500
- Montenegro P, Knuppel R A, Shah D, O'Brien W F. The effect of serotonergic blockade in postpartum preeclamptic patients. Am J Obstet Gynecol. 1985; 153: 130–34
- Hulme V A, Odendaal H J. Intrapartum treatment of preeclamptic hypertension by ketanserin. Am J Obstet Gynecol. 1986; 155: 260–63
- De Clerck F, Symoens J, Janssen P AJ. Vascular protection by ketanserin, a 5-HT2 serotonergic receptor antagonist?. Platelets 1991; 2: 163–66
- De Clerck F. The role of serotonin in thrombogenesis. Clin Physiol. Biochem. 1990; 8(suppl)40–49
- Martin J R, Blake P G, Perry K J, McGaul J F, Hess L W, Martin R W. The natural history of HELLP syndrome: Patterns of disease progression and regression. Am J Obstet Gynecol. 1991; 164: 1513
- Imperiale T F, Petrulus A S. A meta-analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease. JAMA 1991; 266: 260–64
- Heyborne K D, Burke M S, Porreco R P. Prolongation of premature gestation in women with hemolysis, elevated liver enzyme, and low platelets. A report of 5 cases. J Reprod Med. 1990; 35: 53–57
- Van Assche F A, Spitz B. Thromboxane synthetase inhibition in pregnancy-induced hypertension. Am J Obstet Gynecol. 1988; 159: 1015–16
- O'Brien J R. “Exhausted” platelets continue to circulate. Lancet 1978; 2: 1316
- Romero R, Mazor M, Lockwood C J, Emamian M, Belanger K P, Hobbins J C, Duffy T. Clinical significance, prevalence, and natural history of thrombocytopenia in pregnancy-induced hypertension. Am J Perinat. 1989; 6: 32–38
- Sibai B H, Taslimi M M, El-Nazer A, Amon E, Mabie B C, Ryan G M. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol. 1986; 155: 501–09